• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在瑞典,有患皮肤癌的父母或兄弟姐妹对侵袭性和原位皮肤癌风险的影响。

The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden.

作者信息

Hussain Shehnaz K, Sundquist Jan, Hemminki Kari

机构信息

Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden.

出版信息

J Invest Dermatol. 2009 Sep;129(9):2142-7. doi: 10.1038/jid.2009.31. Epub 2009 Feb 26.

DOI:10.1038/jid.2009.31
PMID:19242514
Abstract

Studies suggest that skin cancer aggregates within families; however, the risk of skin cancer associated with having an affected sibling or parent by subtype, tumor site, and age at diagnosis has not been established. The 2006 update of the Swedish Family-Cancer Database was used to calculate standardized incidence ratios (SIRs), representing the ratio of cancer risk among individuals with affected parents or siblings to the general population. Risk of invasive squamous cell skin cancer for individuals with an affected sibling or parent was increased between two- and three-fold compared with that in the general population. For in situ skin tumors, increased SIRs of 1.95-4.30 for squamous cell, Bowen's disease, and actinic keratosis were observed for individuals with affected siblings or parents, and SIRs were generally higher for tumors at sun-exposed versus covered sites. Finally, SIRs for in situ and invasive squamous cell skin cancer increased by increasing number of parental tumors (P< or =0.01). In conclusion, having an affected sibling or parent was associated with an increased risk of skin cancer of varied subtypes compared with that in the general population, and for some subtypes, these familial risks were increased for tumors at sun-exposed sites or by an increasing number of parental tumors.

摘要

研究表明皮肤癌在家族中具有聚集性;然而,与患有皮肤癌的兄弟姐妹或父母相关的、按亚型、肿瘤部位及诊断时年龄划分的皮肤癌风险尚未明确。利用瑞典家族癌症数据库2006年的更新数据来计算标准化发病比(SIR),即有患癌父母或兄弟姐妹的个体患癌风险与普通人群患癌风险之比。有患癌兄弟姐妹或父母的个体发生侵袭性皮肤鳞状细胞癌的风险相较于普通人群增加了2至3倍。对于原位皮肤肿瘤,有患癌兄弟姐妹或父母的个体,鳞状细胞癌、鲍恩病及光化性角化病的SIR升高至1.95至4.30,且暴露于阳光下部位的肿瘤SIR通常高于遮盖部位的肿瘤。最后,原位和侵袭性皮肤鳞状细胞癌的SIR随着患癌父母数量的增加而升高(P≤0.01)。总之,与普通人群相比,有患癌兄弟姐妹或父母会增加多种亚型皮肤癌的风险,对于某些亚型,暴露于阳光下部位的肿瘤或患癌父母数量增加会使这些家族性风险升高。

相似文献

1
The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden.在瑞典,有患皮肤癌的父母或兄弟姐妹对侵袭性和原位皮肤癌风险的影响。
J Invest Dermatol. 2009 Sep;129(9):2142-7. doi: 10.1038/jid.2009.31. Epub 2009 Feb 26.
2
Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.按阳光暴露身体部位划分的侵袭性和原位皮肤黑色素瘤的发病率趋势及家族风险。
Int J Cancer. 2003 May 10;104(6):764-71. doi: 10.1002/ijc.10976.
3
[Squamous cell carcinoma, basalioma and Bowen's disease associated with porokeratosis of Mibelli].
Nihon Hifuka Gakkai Zasshi. 1982 Sep;92(10):1061-4.
4
Time trends and familial risks in squamous cell carcinoma of the skin.皮肤鳞状细胞癌的时间趋势和家族风险
Arch Dermatol. 2003 Jul;139(7):885-9. doi: 10.1001/archderm.139.7.885.
5
Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumors.
J Dermatol Sci. 2000 Dec;24(3):177-83. doi: 10.1016/s0923-1811(00)00096-7.
6
The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.肾移植受者中鳞状细胞癌的较高发病率与端粒长度增加有关。
Hum Pathol. 2007 Feb;38(2):351-8. doi: 10.1016/j.humpath.2006.08.019. Epub 2006 Nov 28.
7
Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.来自2,112,616个核心家庭的兄弟姐妹及父母患癌情况对后代患癌风险的影响
Int J Cancer. 2001 Apr 1;92(1):144-50.
8
Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.神经系统肿瘤的家族风险:来自瑞典和挪威的组织学特异性分析
Lancet Oncol. 2009 May;10(5):481-8. doi: 10.1016/S1470-2045(09)70076-2. Epub 2009 Apr 6.
9
Familial and attributable risks in cutaneous melanoma: effects of proband and age.皮肤黑色素瘤的家族风险和归因风险:先证者及年龄的影响
J Invest Dermatol. 2003 Feb;120(2):217-23. doi: 10.1046/j.1523-1747.2003.12041.x.
10
p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.p53在鲍温病及皮肤微浸润鳞状细胞癌中的表达。
Mod Pathol. 1995 Jun;8(5):526-9.

引用本文的文献

1
Differences of clinical features, prognosis and genetic mutations in Chinese patients with malignant melanoma and additional primary tumours.中国恶性黑色素瘤合并其他原发性肿瘤患者的临床特征、预后及基因突变差异。
Ann Med. 2025 Dec;57(1):2493769. doi: 10.1080/07853890.2025.2493769. Epub 2025 May 3.
2
Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study.免疫抑制实体器官移植受者中角质形成细胞癌遗传风险因素的识别:一项病例对照研究。
Cancers (Basel). 2023 Jun 26;15(13):3354. doi: 10.3390/cancers15133354.
3
Identifying Susceptibility Loci for Cutaneous Squamous Cell Carcinoma Using a Fast Sequence Kernel Association Test.
使用快速序列核关联检验识别皮肤鳞状细胞癌的易感基因座。
Front Genet. 2021 May 10;12:657499. doi: 10.3389/fgene.2021.657499. eCollection 2021.
4
Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.成功使用免疫疗法治疗隐性营养不良型大疱性表皮松解症的晚期皮肤鳞状细胞癌。
BMJ Case Rep. 2021 Feb 26;14(2):e238966. doi: 10.1136/bcr-2020-238966.
5
Epidemiology of nonmelanoma skin cancer in Japan: Occupational type, lifestyle, and family history of cancer.日本非黑色素瘤皮肤癌的流行病学:职业类型、生活方式和癌症家族史。
Cancer Sci. 2020 Nov;111(11):4257-4265. doi: 10.1111/cas.14619. Epub 2020 Sep 9.
6
Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.日光性角化病患者皮肤角质形成细胞癌的预测:多变量风险预测模型的构建与内部验证
Br J Dermatol. 2020 Sep;183(3):495-502. doi: 10.1111/bjd.18810. Epub 2020 Feb 26.
7
Comparison of Familial Clustering of Anogenital and Skin Cancers Between In Situ and Invasive Types.肛门生殖器癌和皮肤癌的原位和侵袭性类型的家族聚集性比较。
Sci Rep. 2019 Nov 6;9(1):16151. doi: 10.1038/s41598-019-51651-6.
8
Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk.量化多基因对皮肤鳞状细胞癌风险的贡献。
J Invest Dermatol. 2018 Jul;138(7):1507-1510. doi: 10.1016/j.jid.2018.01.031. Epub 2018 Feb 13.
9
Management of a cutaneous squamous cell carcinoma overlying an AV fistula.动静脉内瘘上方皮肤鳞状细胞癌的管理
BMJ Case Rep. 2017 May 6;2017:bcr-2016-218932. doi: 10.1136/bcr-2016-218932.
10
Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma.皮肤鳞状细胞癌易感性位点的鉴定
J Invest Dermatol. 2016 May;136(5):930-937. doi: 10.1016/j.jid.2016.01.013. Epub 2016 Jan 29.